Browsed by
Tag: Oxford

Oxford Finance Provides $55 Million Credit Facility to SpendMend

Oxford Finance Provides $55 Million Credit Facility to SpendMend

ALEXANDRIA, Va. and GRAND RAPIDS, Mich., Oct. 8, 2020 /PRNewswire/ — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a $55 million senior credit facility and revolving line of credit to SpendMend (or “the Company”), a portfolio company of Sheridan Capital Partners.

The proceeds were used to refinance existing debt, fund the acquisition of Turnkey Pharmacy Solutions (“Turnkey”) and Elevate340B (“Elevate”), and provide ongoing working capital. Oxford Finance is the sole lead arranger and administrative agent in this transaction.

Established in 1993, SpendMend is the leading outsourced provider of cost cycle management services and tech-enabled solutions to the healthcare market. A majority of the nation’s top healthcare systems partner with SpendMend to improve patient care through innovative cost-savings solutions.

“SpendMend is a recognized leader in cost cycle management,” said Tracy S. Maziek, head of healthcare services at Oxford Finance. “The Company provides tangible value and bottom-line impact to a complex industry operating on thin margins. The continued growth of these businesses, in spite of the global impacts of COVID, strengthened our conviction and validated the compelling value propositions of these businesses. Oxford is happy to be working with the Sheridan team once again and to now be supporting SpendMend.”

“The acquisition of Turnkey and Elevate broadens our suite of offerings providing compliance, optimization and growth services for the complex and critical 340B programs at health systems,” stated Dan Geehoed, CEO of SpendMend. “Oxford provided a flexible financing solution to support this acquisition and will be a valuable partner to support our continued growth.”

“Oxford was able to deliver a compelling proposal on an expedited timeline and with a high degree of certainty,” added Nick Rowland, principal at Sheridan Capital Partners. “We are pleased

Read the rest